Brought to you by 
Zai Lab raises $30mm in Series C round
30 Jun 2017
Executive Summary
Zai Lab Ltd. (Chinese biopharmaceutical company) raised $30mm in its Series C financing round. The round was led by OrbiMed along with additional new investors Vivo Capital, Cormorant, and Rock Springs Capital. The company will use the offering proceeds to fund its R&D and for future partnering. Back in 2016, Zai raised a large B round at $100mm.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Zai Lab raises $30mm in Series C round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice